Xuezhong Yang

Hematology & Oncology Greenville, SC Male
NPI: 1598922650
Total Payments
$2,424
2024 Payments
$143.38
Companies
34
Transactions
121
Medicare Patients
2,774
Medicare Billing
$532,794

Payment Breakdown by Category

Food & Beverage$2,168 (89.4%)
Education$256.50 (10.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,168 112 89.4%
Education $256.50 9 10.6%

Top Paying Companies

Company Total Records Latest Year
Adaptive Biotechnologies Corporation $280.52 2 $0 (2024)
Astellas Pharma US Inc $254.36 9 $0 (2019)
PFIZER INC. $249.18 14 $0 (2021)
E.R. Squibb & Sons, L.L.C. $197.29 16 $0 (2023)
Celgene Corporation $185.95 4 $0 (2023)
Merck Sharp & Dohme LLC $138.06 11 $0 (2022)
Teva Pharmaceuticals USA, Inc. $124.44 3 $0 (2018)
GENZYME CORPORATION $120.05 6 $0 (2023)
Novartis Pharmaceuticals Corporation $103.97 8 $0 (2019)
TAIHO ONCOLOGY, INC. $93.32 5 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $143.38 1 Adaptive Biotechnologies Corporation ($143.38)
2023 $367.45 13 Adaptive Biotechnologies Corporation ($137.14)
2022 $76.28 5 Merck Sharp & Dohme LLC ($21.43)
2021 $25.06 2 PFIZER INC. ($25.06)
2020 $41.48 3 Merck Sharp & Dohme Corporation ($17.29)
2019 $766.27 42 Astellas Pharma US Inc ($254.36)
2018 $624.35 25 PFIZER INC. ($165.70)
2017 $379.83 30 E.R. Squibb & Sons, L.L.C. ($69.04)

All Payment Transactions

121 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
05/14/2024 Adaptive Biotechnologies Corporation clonoSEQ (Device) Food and Beverage Cash or cash equivalent $143.38 General
Category: ONCOLOGY
10/25/2023 Adaptive Biotechnologies Corporation clonoSEQ (Device) Food and Beverage Cash or cash equivalent $137.14 General
Category: ONCOLOGY
04/26/2023 SERVIER PHARMACEUTICALS LLC Tibsovo (Drug), Oncaspar Food and Beverage In-kind items and services $24.75 General
Category: Oncology
04/26/2023 Acrotech Biopharma Inc. BELEODAQ (Drug) Food and Beverage In-kind items and services $22.75 General
Category: ONCOLOGY
04/13/2023 E.R. Squibb & Sons, L.L.C. — Food and Beverage Cash or cash equivalent $12.90 General
04/11/2023 Incyte Corporation MONJUVI (Drug), PEMAZYRE, JAKAFI Food and Beverage Cash or cash equivalent $17.39 General
Category: Oncology
03/14/2023 GENZYME CORPORATION SARCLISA (Biological) Food and Beverage In-kind items and services $25.68 General
Category: Oncology
03/03/2023 Celgene Corporation Pomalyst (Drug) Food and Beverage Cash or cash equivalent $18.17 General
Category: Hematology
02/22/2023 AbbVie Inc. VENCLEXTA (Drug) Food and Beverage In-kind items and services $21.45 General
Category: ONCOLOGY
02/21/2023 GENZYME CORPORATION JEVTANA (Drug) Food and Beverage In-kind items and services $20.05 General
Category: Oncology
02/03/2023 TAIHO ONCOLOGY, INC. LONSURF (Drug), INQOVI Food and Beverage In-kind items and services $18.19 General
Category: Oncology
02/02/2023 Celgene Corporation OPDUALAG (Drug) Food and Beverage Cash or cash equivalent $13.49 General
Category: Oncology
01/27/2023 Mirati Therapeutics, Inc. KRAZATI (Drug) Education In-kind items and services $21.00 General
Category: ONCOLOGY
01/10/2023 TAIHO ONCOLOGY, INC. LONSURF (Drug), INQOVI Food and Beverage In-kind items and services $14.49 General
Category: Oncology
12/14/2022 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $10.58 General
Category: ONCOLOGY
12/02/2022 Genentech USA, Inc. Perjeta (Biological), Kadcyla, Phesgo Food and Beverage In-kind items and services $16.45 General
Category: BioOncology
11/09/2022 Taiho Oncology, Inc. LONSURF (Drug), INQOVI Food and Beverage In-kind items and services $19.71 General
Category: Oncology
11/01/2022 Amgen Inc. Nplate (Biological), XGEVA Food and Beverage In-kind items and services $18.69 General
Category: Hematology
03/15/2022 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Education In-kind items and services $10.85 General
Category: ONCOLOGY
04/30/2021 PFIZER INC. IBRANCE (Drug), TALZENNA Food and Beverage In-kind items and services $13.16 General
Category: ONCOLOGY
01/26/2021 PFIZER INC. LORBRENA (Drug) Education In-kind items and services $11.90 General
Category: ONCOLOGY
03/10/2020 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $14.35 General
Category: Hematology/Oncology
02/05/2020 Merck Sharp & Dohme Corporation KEYTRUDA (Biological) Food and Beverage In-kind items and services $17.29 General
Category: ONCOLOGY
01/17/2020 Clovis Oncology, Inc. Rubraca (Drug) Food and Beverage In-kind items and services $9.84 General
Category: Oncology
12/31/2019 Pharmacyclics LLC, An AbbVie Company Imbruvica (Drug) Food and Beverage In-kind items and services $11.61 General
Category: Oncology
123…5»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 607 1,203 $277,623 $137,054
2022 11 590 1,101 $250,266 $119,987
2021 10 686 1,306 $284,166 $137,236
2020 9 891 1,626 $328,002 $138,517
Total Patients
2,774
Total Services
5,236
Medicare Billing
$532,794
Procedure Codes
40

All Medicare Procedures & Services

40 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 108 493 $123,303 $64,810 52.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 205 355 $66,030 $31,775 48.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 83 83 $23,738 $9,608 40.5%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 50 50 $17,800 $7,799 43.8%
99496 Transitional care management services for problem of high complexity Office 2023 25 31 $9,393 $6,542 69.6%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 45 46 $11,224 $4,628 41.2%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 34 68 $8,772 $4,163 47.5%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 26 44 $8,096 $4,053 50.1%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 17 18 $6,462 $2,351 36.4%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 14 15 $2,805 $1,325 47.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 88 417 $104,118 $54,589 52.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 196 331 $61,476 $29,259 47.6%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 59 59 $21,004 $9,443 45.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 72 72 $20,592 $8,311 40.4%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 28 28 $10,052 $4,106 40.9%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 38 68 $8,772 $3,496 39.9%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 32 32 $7,808 $2,866 36.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 36 39 $4,869 $2,387 49.0%
99496 Transitional care management services for problem of high complexity Office 2022 11 12 $3,630 $2,365 65.2%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 19 32 $5,888 $2,357 40.0%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 11 11 $2,057 $807.51 39.3%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 99 465 $115,320 $60,433 52.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 218 367 $67,528 $32,332 47.9%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 67 67 $19,162 $7,931 41.4%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 48 48 $17,088 $7,853 46.0%
12»

About Xuezhong Yang

Xuezhong Yang is a Hematology & Oncology healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1598922650.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Xuezhong Yang has received a total of $2,424 in payments from pharmaceutical and medical device companies, with $143.38 received in 2024. These payments were reported across 121 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($2,168).

As a Medicare-enrolled provider, Yang has provided services to 2,774 Medicare beneficiaries, totaling 5,236 services with total Medicare billing of $532,794. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.

Practice Information

  • Specialty Hematology & Oncology
  • Location Greenville, SC
  • Active Since 05/16/2008
  • Last Updated 06/15/2012
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1598922650

Products in Payments

  • clonoSEQ (Device) $280.52
  • Revlimid (Drug) $154.29
  • IBRANCE (Drug) $111.54
  • SUTENT (Drug) $101.33
  • KEYTRUDA (Biological) $92.65
  • OPDIVO (Biological) $81.47
  • Venclexta (Drug) $69.61
  • XTANDI (Drug) $65.07
  • LONSURF (Drug) $52.39
  • Imbruvica (Drug) $46.40
  • ZOLADEX (Drug) $43.48
  • JAKAFI (Drug) $42.75
  • LIBTAYO (Drug) $42.39
  • Lonsurf (Drug) $40.93
  • Avastin (Biological) $38.63
  • SPRYCEL (Drug) $38.33
  • VOTRIENT (Drug) $33.94
  • JEVTANA (Drug) $32.26
  • EMEND (Drug) $29.54
  • EMPLICITI (Biological) $26.95

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Greenville

Dr. Suzanne Fanning, D.o, D.O

Hematology & Oncology — Payments: $1.3M

Hematology & Oncology $1.3M

Dr. Joe Stephenson, Md, MD

Hematology & Oncology — Payments: $137,970

Hematology & Oncology $137,970

Dr. Paul Walker, M.d, M.D

Hematology & Oncology — Payments: $66,454

Hematology & Oncology $66,454

Dr. Darla Liles, Md, MD

Hematology & Oncology — Payments: $49,052

Hematology & Oncology $49,052

William Edenfield, Md, MD

Hematology & Oncology — Payments: $31,038

Hematology & Oncology $31,038

Dr. Raid Aljumaily, M.d, M.D

Hematology & Oncology — Payments: $21,498

Hematology & Oncology $21,498